tiprankstipranks

Carsten Brunn Insider Profile

11 Followers
Carsten Brunn, President & CEO, Director at Cartesian Therapeutics, holds 204.10K shares in Cartesian Therapeutics (Ticker: RNAC), holds ― shares in Surface Oncology (Ticker: SURF). Most recently, Carsten Brunn Sold ― shares of Cartesian Therapeutics on Jan 07, 2025 for an estimated value of 289.73K.
tipranks
Carsten Brunn

Carsten Brunn
Cartesian Therapeutics (RNAC)
President & CEO, Director

Ranked #3,769 out of 100,285 Corporate Insiders

Profitable Transactions

100%
8 out of 8 Profitable Transactions

Average Return

+43.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Carsten Brunn's holdings

Insider Roles

Cartesian Therapeutics
(RNAC)
President & CEO, Director
Roles that Carsten Brunn holds in companies

Most Profitable Insider Trade

Stock:
Cartesian Therapeutics
(RNAC)
Rating:Informative Sell
Date:Oct 15, 2021 - Oct 15, 2022
Return:+64.10%
The most profitable trade made by Carsten Brunn

Carsten Brunn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cartesian Therapeutics
Jan 07, 2025
President & CEO, Director
Informative Sell
289.73K
$3.94M
SURF
Surface Oncology
List of latest transactions for each holding click on a transaction to see Carsten Brunn's performance on stock

Carsten Brunn insider profile FAQ

What is the percentage of profitable transactions made by Carsten Brunn?
The percentage of profitable transactions made by Carsten Brunn is 100%.
    What is the average return per transaction made by Carsten Brunn?
    The average return per transaction made by Carsten Brunn is 43.90%.
      What stocks does Carsten Brunn hold?
      Carsten Brunn holds: RNAC, SURF stocks.
        What was Carsten Brunn’s latest transaction?
        Carsten Brunn latest transaction was an Informative Sell of $289.73K.
          What was Carsten Brunn's most profitable transaction?
          Carsten Brunn’s most profitable transaction was an Informative Sell of RNAC stock on October 15, 2021. The return on the trade was 64.10%.
            What is Carsten Brunn's role in Cartesian Therapeutics?
            Carsten Brunn's role in Cartesian Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.